FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 3, 2019--
MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Central
Coast Perinatal Medical Group, Inc., a private maternal-fetal medicine
practice based in Santa Barbara, Calif.
Founded in 1993, Central Coast Perinatal is an established group that
has provided perinatal services to the Central Coast community for more
than 25 years. Comprising three physicians, the practice specializes in
care for expectant mothers, including those with high-risk pregnancies.
Central Coast Perinatal provides services to two regional hospitals,
Santa Barbara Cottage Hospital and Ventura County Medical Center; one
private OBGYN group, San Dimas Medical Group; and two outpatient
facilities in Santa Barbara and Ventura.
“Becoming part of the MEDNAX national network gives us the
infrastructure we need to excel in today’s evolving healthcare
environment while continuing to provide outstanding patient care,” said
Alex Soffici, M.D., who will serve as medical director for the practice.
“Additionally, MEDNAX’s nationally-recognized research, education and
quality initiatives will further enhance our practice and the care we
deliver.”
This affiliation adds to the services MEDNAX provides in California
through its affiliated network of physicians across multiple
specialties, including maternal-fetal medicine, neonatology, newborn
hearing screen, obstetric hospitalist, pediatric cardiology, pediatric
critical care, pediatric hospitalist and radiology.
MEDNAX’s affiliated physician practices provide excellent Women’s and
Children’s care in the Central Coast community. Its physician network
provides maternal-fetal medicine, neonatology and pediatric critical
care services to nine area hospital partners.
This was a cash transaction and it is expected to be immediately
accretive to earnings. No additional terms of the transaction were
disclosed.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner based in Sunrise,
Fla. comprised of the nation's leading providers of physician services.
Physicians and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, clinical research and telemedicine to enhance patient
outcomes and provide high-quality, cost-effective care. The Company was
founded in 1979, and today, through its affiliated professional
corporations, MEDNAX provides services through a network of more than
4,200 physicians in all 50 states and Puerto Rico. In addition to its
national physician network, MEDNAX provides services to healthcare
facilities and physicians in over 40 states through two complementary
businesses, consisting of a revenue cycle management company and a
consulting services company. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,”
“will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could
cause actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K,filed with the Securities and Exchange
Commission, and include the effects of economic conditions on MEDNAX’s
business; the effects of the Affordable Care Act and potential changes
thereto or a repeal thereof; MEDNAX’s relationships with
government-sponsored or funded healthcare programs, including Medicare
and Medicaid, and with managed care organizations and commercial health
insurance payors; MEDNAX’s ability to consummate the proposed
disposition of MedData; the effects of share repurchases; and the
effects of MEDNAX’s shared services and operational initiatives.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190503005024/en/
Source: MEDNAX, Inc.
Charles Lynch
Vice President, Strategy and Investor Relations
954-384-0175
ext. 5692
charles_lynch@mednax.com